Evidence map›Paper›PMID 42515813›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Correction: Wali et al. Epigenetic Alterations in Hepatocellular Carcinoma: Mechanisms, Biomarkers, and Therapeutic Implications.

Adil Farooq Wali, Abid Reza Ansari, Prince Ahad Mir, Mohamed El-Tanani, Rasha Babiker, Md Sadique Hussain, Jasreen Uppal, Asma Ishrat Zargar, Reyaz Hassan Mir

Abstract readPublished Erratum
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Adil Farooq WaliRAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates.ORCID 0000-0003-1555-2820
Abid Reza AnsariLaboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar (Mohali) 160062, Punjab, India.ORCID 0009-0006-3996-882X
Prince Ahad MirDepartment of Pharmacognsoy and Phytochemistry, Khalsa College of Pharmacy, G.T. Road, Amritsar 143002, Punjab, India.ORCID 0000-0001-6512-9866
Mohamed El-TananiRAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates.ORCID 0000-0002-4735-5445
Rasha BabikerDepartment of Physiology, RAK College of Medical Sciences, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates.ORCID 0000-0002-9456-2033
Md Sadique HussainUttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun 248007, Uttarakhand, India.ORCID 0000-0002-3554-1750
Jasreen UppalDepartment of Pharmacognsoy and Phytochemistry, Khalsa College of Pharmacy, G.T. Road, Amritsar 143002, Punjab, India.ORCID 0000-0001-7208-8396
Asma Ishrat ZargarPharmacology Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar 190006, Jammu and Kashmir, India.
Reyaz Hassan MirPharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar 190006, Jammu and Kashmir, India.ORCID 0000-0002-6825-1338

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the published manuscript [...].

Identifiers

PMID42515813
PMCPMC13416367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.